MA
ABBV icon

MBA Advisors’s AbbVie ABBV Stock Holding History

MBA Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26M Buy
5,807
+679
+13% +$151K 0.49% 45
2025
Q4 		$1.17M Sell
5,128
-92
-2% -$21K 0.47% 47
2025
Q3 		$1.21M Sell
5,220
-405
-7% -$82.5K 0.52% 42
2025
Q2 		$1.04M Sell
5,625
-215
-4% -$40K 0.48% 49
2025
Q1 		$1.22M Buy
5,840
+96
+2% +$18.7K 0.61% 37
2024
Q4 		$1.02M Sell
5,744
-486
-8% -$89.4K 0.51% 47
2024
Q3 		$1.23M Buy
6,230
+12
+0.2% +$2.24K 0.59% 43
2024
Q2 		$1.07M Buy
6,218
+495
+9% +$82K 0.55% 45
2024
Q1 		$1.04M Sell
5,723
-423
-7% -$72.9K 0.54% 48
2023
Q4 		$952K Sell
6,146
-135
-2% -$19.7K 0.53% 47
2023
Q3 		$936K Buy
6,281
+19
+0.3% +$2.79K 0.57% 45
2023
Q2 		$844K Buy
6,262
+41
+0.7% +$6.01K 0.5% 48
2023
Q1 		$991K Buy
6,221
+169
+3% +$25.8K 0.62% 47
2022
Q4 		$978K Buy
6,052
+198
+3% +$30.4K 0.64% 43
2022
Q3 		$786K Buy
5,854
+604
+12% +$86.7K 0.57% 47
2022
Q2 		$804K Sell
5,250
-83
-2% -$12.7K 0.55% 51
2022
Q1 		$864K Sell
5,333
-786
-13% -$114K 0.54% 54
2021
Q4 		$828K Buy
6,119
+651
+12% +$76.9K 0.51% 54
2021
Q3 		$590K Buy
5,468
+61
+1% +$6.97K 0.44% 64
2021
Q2 		$609 Sell
5,407
-366
-6% -$41.2K 0.28% 62
2021
Q1 		$625 Buy
+5,773
New +$617K 0.34% 59

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MBA Advisors's ABBV Position: Q1 2026 in Review

MBA Advisors increased its AbbVie (ABBV) stake by 13% in Q1 2026, buying an estimated $151K and bringing the position to 5,807 shares worth $1.26M. The position accounts for 0.49% of the portfolio, ranked #45.

MBA Advisors first reported a position in ABBV in Q1 2021 and has held it in 21 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • MBA Advisors held 5,807 shares of AbbVie worth $1.26M as of Q1 2026.
  • MBA Advisors bought 679 AbbVie shares in Q1 2026, an estimated $151K.
  • AbbVie made up 0.49% of MBA Advisors's portfolio in Q1 2026, its #45 holding.
  • MBA Advisors first reported a position in AbbVie in Q1 2021 and has held it in 21 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MBA Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.